|Articles|January 11, 2022
- Pharmaceutical Executive-01-01-2022
- Volume 42
- Issue 1
Pharmaceutical Executive, January 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive January 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 4 years ago
Keeping Tabs on Quality: The Rise of Digitalabout 4 years ago
China Invests in Building Biotechabout 4 years ago
Branding Takes on a New Lookabout 4 years ago
Addressing Access Burdensabout 4 years ago
Meeting the Patient—Virtuallyabout 4 years ago
The Age of Influenceabout 4 years ago
Boosting Immunotherapiesabout 4 years ago
Pharma’s Psychedelic Experienceabout 4 years ago
Supply Chain Procurementabout 4 years ago
Our View on 2022: Pharm Exec’s Annual Industry OutlookNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

